Current Opinion in Critical Care was launched in 1995. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of critical care is divided into 13 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the journal's Section Editors for this issue.
Prof. Thomas Rimmelé is the Chairman of the Department of Anaesthesiology and Intensive Care Medicine at Edouard Herriot Hospital, Lyon, France, and Chairman of the Department of Organ Harvest Coordination for the Hospices Civils de Lyon, France. He gained his medical degree in 2004, specialising in anaesthesiology and intensive care, from the Claude Bernard University, Lyon, France, and subsequently completed a PhD on extracorporeal blood purification therapies in sepsis.
In addition to blood purification for sepsis, Prof. Rimmelé's academic interests include acute kidney injury, renal replacement therapy in the intensive care unit, and simulation in healthcare as he is also the co-director of the simulation center at Lyon University, France. Prof. Rimmelé is the author or co-author of more than 150 peer-reviewed articles or book chapters and regularly delivers lectures at international meetings.
Wesley H. Self
Dr Wesley H. Self, MD, MPH, is the Vice Chair for Research in the Department of Emergency Medicine at Vanderbilt University Medical Center in Nashville, Tennessee, USA. He is an emergency physician and clinical researcher focused on the intersection of emergency and critical care medicine. He has authored over 100 peer-reviewed publications and widely lectured and presented research findings on the early management of pneumonia, sepsis, and related emergencies.
Dr Self was the principal investigator for the Saline Against Lactated Ringer's or Plasmalyte in the Emergency Department (SALT-ED) trial (N Engl J Med 2018), which demonstrated a lower incidence of major adverse kidney events following IV fluid resuscitation with balanced crystalloids compared with saline. He was also a lead investigator in the Etiology of Pneumonia in the Community (EPIC) study (N Engl J Med 2015), which demonstrated a high disease burden from respiratory viruses among patients hospitalized with community-acquired pneumonia in the United States. Dr Self serves as the co-principal investigator of the Vanderbilt Clinical Center in the Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network (http://www.petalnet.org) funded by the National Heart, Lung and Blood Institute (NHLBI). His current work focuses on embedding pragmatic comparative effectiveness trials into ongoing clinical care to learn how to improve early resuscitation.
Dr Self completed medical school at the University of Virginia, USA, residency training in emergency medicine at Northwestern University, USA, and a clinical research fellowship at Vanderbilt University, USA. He is currently an Associate Professor of Emergency Medicine at Vanderbilt University Medical Center, where he leads the Division of Emergency Medicine Research.
Prof. Karim Asehnoune got his degree as an MD in 1999 at University René Descartes Paris, France. After completing his PhD in immunology in 2001, he spent one year in the lab of Prof. Edward Abraham in the University of Colorado, Denver, USA (2002). He was appointed Professor of Anaesthesiology and Critical Care Medicine in the University of Nantes, France, in 2009.
Prof. Asehnoune is the head of the Anaesthesiology department of Hospital Hotel-Dieu, and the director of the 30-bed surgical Intensive Care Unit at the University hospital of Nantes, France. He is currently a member of the scientific committee of the French Society of Anaesthesiology and Critical Care Medicine, and the director of a French network of ICUs (http://www.ATLANREA.org). Professor Asehnoune was involved as the coordinator of several multi-centre trials, and he was the primary investigator of 2 multicentre double blind randomised studies evaluating corticosteroids in severe trauma patients. He is the director of a lab dedicated to the study of host-pathogen interactions (http://www.ea3826.univ-nantes.fr/). He has published more than 180 peer-reviewed articles.